Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 21 Issue 10, October 2015

In this issue, Min et al. (p 1154) identify acetylation of tau at site K174 as an early pathological change in human Alzheimer's Disease (AD) brain tissue and show that this acetylation exacerbates tau-mediated neurodegeneration and memory impairments in mice. Furthermore, pharmacological inhibition of tau acetylation can ameliorate these phenotypes in a mouse model of AD/FTD (frontotemporal dementia). The cover image depicts immunostaining for AC312-positive acetylated tau (red and magenta) and MC1-positive pathological tau (blue and green) in the hippocampus of the PS19 transgenic mouse model of AD/FTD. Image credit: the original image is by Chao Wang, and the artwork is by Connor Ludwig.

Editorial

  • The proposed 21st Century Cures Act is a potential boon to the funding woes faced by the US National Institutes of Health and the Food and Drug Administration. But a careful look at the provisions within the bill is warranted to avoid enacting policies that could undermine the progressive translation of research into clinical products.

    Editorial

    Advertisement

Top of page ⤴

News Feature

Top of page ⤴

News

Top of page ⤴

News Feature

Top of page ⤴

Opinion

  • The Canadian Institutes of Health Research (CIHR) recently terminated its MD/PhD training program without clear alternative funding in place. This misguided decision must urgently be reversed, as it has the potential to diminish a unique pool of graduates at the forefront of translational research.

    • Ryan T Lewinson
    • Craig A Beers
    • Michael A Peplowski
    Opinion
Top of page ⤴

News in Brief

Top of page ⤴

Correspondence

Top of page ⤴

News & Views

  • The role of CD47—often expressed on tumor cells—as a 'don't eat me' signal that inhibits macrophage phagocytosis is well established. But new work reveals a major role for other immune cell types—T cells and dendritic cells—in the anti-tumor effects of therapeutic CD47 blockade.

    • Robert H Vonderheide
    News & Views
  • During viral infections, antigen-presenting cells (APC) have traditionally been thought to recruit and activate CD4+ T cells by presenting fragments of viral proteins captured from the extracellular environment. A new study indicates that the material the APCs need to present is much closer: in fact, APCs need to make it themselves.

    • Justine D Mintern
    • Jose A Villadangos
    News & Views
  • Depression is mechanistically not well understood. A new study investigates the expression of chromatin-remodeling complexes in a mouse model for depression and describes an epigenetic pathway that may explain why some individuals are more susceptible to stress-induced depression than others.

    • Farahnaz Sananbenesi
    • Andre Fischer
    News & Views
  • Several independent groups question the reliability of an antibody-based method that is used to isolate oogonial stem cells from the ovaries of adult humans, nonhuman primates and mice.

    • David F Albertini
    • Norbert Gleicher
    News & Views
Top of page ⤴

Review Article

Top of page ⤴

Brief Communication

Top of page ⤴

Article

Top of page ⤴

Letter

Top of page ⤴

Resource

Top of page ⤴

Search

Quick links